En Es
Categories

Industry News


Siemens Healthineers' Acquires Corindus to Enhance Robotic-Assisted Interventions

By Medimaging International staff writers
13 Aug 2019

Image: The CorPath GRX system (Photo courtesy of Corindus).Siemens Healthineers AG (Erlangen, Germany) has entered into a merger agreement with Corindus Vascular Robotics, Inc. (Boston, MA. USA) to acquire the company, which offers a robotic treatment platform for the major vascular therapeutic markets, including coronary, peripheral vascular and neurovascular interventions.

Corindus develops, produces and sells robotic systems for minimally invasive procedures. These systems help doctors to precisely control guide catheters, guide wires, balloon or stent implants via integrated imaging. The physician does not have to stand at the angiography table as usual but can control the procedure with a separate controlling module and is therefore, less exposed to radiation.

Siemens Healthineers’ acquisition of Corindus meets its objective of simplifying today's challenges in everyday hospital life. Robotic assisted minimally invasive procedures have the potential to reduce treatment times, increase precision during treatment, raise standardization levels in clinical procedures and ultimately improve clinical outcomes, which is the strategic focus of Siemens Healthineers’ Advanced Therapies business segment.

The CorPath systems developed by Corindus will be used along with angiography systems sold by Siemens Healthineers that make minimally invasive treatment possible by using high-quality imaging before and during medical interventions. The company's role in image-based minimally invasive procedures is now complemented by robotic-assisted precision medicine. This expansion strengthens Siemens Healthineers’ therapy position and underlines its role as one of the leading providers of solutions along the entire treatment path. The acquisition of Corindus marks a strategically significant extension of Siemens Healthineers’ therapy business.

The future integration of Siemens Healthineers’ digitization and artificial intelligence solutions with Corindus' robotic systems offers further promising possibilities. The aim is to further increase procedure optimization in order to enable the greatest possible degree of efficiency and clinical reproducibility. Additionally, Corindus is driving forward the approval procedure for remote robotic treatment in vascular interventions. Due to the limited availability of specialists for minimally invasive procedures in many regions and the limited number of corresponding clinical facilities, remote treatment could significantly improve patients' access to treatment in the future.

“Together with Corindus, Siemens Healthineers is well-positioned to be one of the leading players in the field of robotic vascular interventions and to perform minimally invasive procedures more accurately, more quickly and more effectively. With this acquisition, we are opening up a new field for our image-guided therapies business. Together with our strong portfolio in imaging, digitalization and artificial intelligence, we are creating significant synergies to advance therapy outcomes,” said Bernd Montag, CEO of Siemens Healthineers AG.

“The interplay of exact imaging and robotic-assisted interventions will enhance both the eyes and hands of the physician, metaphorically speaking. With the addition of Corindus to our strong therapies portfolio we sharpen our procedural focus and will grow by expanding precision medicine and improving clinical outcomes. In the future, our digital and artificial intelligence-based tools will help to integrate the aspects of image-guidance and therapy even further,” said Michel Therin, President Advanced Therapies at Siemens Healthineers.

“The collaboration with Siemens Healthineers is a unique opportunity to take our business to the next level and continue our success story. Together we plan to develop next-generation solutions that further improve patient care,” said Mark Toland, President and CEO at Corindus.



E-mail Print
FaceBook Twitter Google+ Linked in

Siemens Healthineers

Provides customized electronic systems and advanced imaging, diagnostics, therapy, and healthcare IT solutions for the medical industry
Gold member
More info

More articles about Siemens Healthineers

05 Aug 2019
Siemens Healthineers Receives Recognition AI Applications in Radiology
Based on its recent analysis of the global precision imaging market, Frost & Sullivan, a growth strategy consulting and research firm, has recognized Siemens Healthineers with the 2019 Global Visionary Innovation Leadership Award for leading the effort to establish imaging as an active contributor to precision medicine.
Read More
07 Feb 2019
Global MRI Systems Market to Grow by USD 1.5 Billion in 2019-2023
The global MRI systems market size is projected to grow at a CAGR of more than 5%, or by almost USD 1.58 billion, during the forecast period 2019-2023, driven primarily by technological advances.
Read More
12 Nov 2018
Siemens Healthineers and Primary Health Care Enter Contract for In Vitro Diagnostics
Siemens Healthineers has entered into a strategic partnership with Australian integrated healthcare provider Primary Health Care to deploy more than 70 Atellica Solution immunoassay and clinical chemistry analyzers, marking the largest contract ever for in vitro diagnostics testing in the country.
Read More
06 Jun 2018
Siemens Healthineers and ScreenPoint Medical to Develop AI-Based Apps
Siemens Healthineers and ScreenPoint Medical have entered into a partnership to develop artificial intelligence (AI)-based applications for breast imaging. As part of the arrangement, Siemens Healthineers will also acquire a strategic minority stake in ScreenPoint Medical.
Read More
26 Apr 2018
Siemens Healthineers Launches Thermocycler with AI-Powered Software
Siemens Healthineers launched a new molecular thermocycler, the Fast Track cycler (FTC), and the complementary new FastFinder software at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2018). The compact FTC allows laboratories of all sizes to implement molecular testing with simplicity and speed, while the FastFinder software improves workflow using Artificial Intelligence (AI)-powered automation.
Read More
27 Feb 2018
Siemens Healthineers AG IPO Planned for First Half of 2018
Global technology powerhouse Siemens AG and its separately managed healthcare business, Siemens Healthineers have announce that the planned IPO of Siemens Healthineers AG is expected to be completed in the first half of calendar year 2018, subject to capital market conditions.
Read More
18 Jan 2018
Siemens Healthineers Strategy 2025 to Focus on AI
Siemens Healthineers has laid out its strategy to bolster its market leadership by 2025 and beyond, aimed at accelerating profitable growth and delivering return. The company has stated that it is well prepared to take advantage of the paradigm shift and structural growth opportunities in healthcare.
Read More
18 Dec 2017
Siemens Healthineers Acquires Fast Track Diagnostics
Siemens Healthineers has entered into an agreement to acquire Fast Track Diagnostics, which supplies diagnostics tests that can distinguish between viral, bacterial, or other infections in one test.
Read More

Additional news

18 Sep 2019
AI Solution Supporting Wins Best New Radiology Solution Award
An FDA-cleared artificial intelligence (AI) solution that supports breast cancer detection in 3D tomosynthesis has been selected as the winner of “Best New Radiology Solution” Award in the 2019 MedTech Breakthrough Awards program.
Read More
18 Sep 2019
Researchers Develop New AI Technology for Heart Attack Prediction
Researchers from the University of Oxford have developed a technology using artificial intelligence (AI) that could identify people at high risk of a fatal heart attack at least five years before it strikes.
Read More
18 Sep 2019
Quality Processes Fueling Global Refurbished Imaging Equipment Market
The market adoption of refurbished imaging equipment is being fueled by quality refurbishment processes, regulatory relaxations, persuasiveness of a circular economy, and new marketing channels. These are the latest findings of Research and Markets, a global market research company.
Read More
18 Sep 2019
Global POC Testing Market to Reach USD 30 Billion by 2022
The global Point-of-Care (POC) testing market is projected to reach USD 30 billion by 2022, driven by the immense potential of POC tests to improve global health and eventually reduce public and national spending on health.
Read More
18 Sep 2019
Baxter Acquires Cheetah Medical to Expand Specialized Patient Portfolio
Baxter International Inc., a global medical products company, has acquired Cheetah Medical, a provider of non-invasive hemodynamic monitoring technologies.
Read More
12 Sep 2019
ERBA Mannheim Opens New Subsidiary in Brazil
ERBA Mannheim has expanded its global footprint by opening a new subsidiary in Brazil.
Read More
10 Sep 2019
Imaging Informatics Summit Highlights Impact of AI Technologies on Patient Care
The 2019 Imaging Informatics Summit organized by the American College of Radiology will be held in Washington, D.C., USA, on October 5–6, 2019, and will focus on the role that artificial intelligence (AI) and data can play in improving patient care.
Read More
10 Sep 2019
ZOLL Medical Completes Acquisition of Cardiac Science
ZOLL Medical Corporation, which manufactures medical devices and related software solutions, has completed the previously announced acquisition of Cardiac Science Corporation, a provider of automated external defibrillators (AEDs), related services, and accessories.
Read More
10 Sep 2019
Growing Inclination Towards Handheld Ultrasound Scanners for POC Diagnostics
The global handheld ultrasound scanners market was valued at USD 62.2 million in 2017 and is projected to grow at a CAGR of 17% during the forecast period 2018-2026, driven primarily by their increasingly popularity among clinicians across the world for point-of-care diagnosis.
Read More
Copyright © 2000-2019 TradeMed.com. All rights reserved. | Terms And Conditions